Rabbani SI

References (3)

Title : Novel ibuprofen prodrug: A possible promising agent for the management of complications of Alzheimer's disease - Nayak_2024_Saudi.Pharm.J_32_101888
Author(s) : Nayak A , Raju R , Das P , Das K , Suvitha A , Ranjan Meher B , Alobid S , Almoteer AI , Almadani ME , Alshehri A , Alghamdi A , Ahmad F , Rabbani SI , Asdaq SMB , Nayeem N
Ref : Saudi Pharm J , 32 :101888 , 2024
Abstract : Nayak_2024_Saudi.Pharm.J_32_101888
ESTHER : Nayak_2024_Saudi.Pharm.J_32_101888
PubMedSearch : Nayak_2024_Saudi.Pharm.J_32_101888
PubMedID: 38090736

Title : Piracetam as a Therapeutic Agent for Doxorubicin-Induced Cognitive Deficits by Enhancing Cholinergic Functions and Reducing Neuronal Inflammation, Apoptosis, and Oxidative Stress in Rats - Mani_2022_Pharmaceuticals.(Basel)_15_
Author(s) : Mani V , Rabbani SI , Shariq A , Amirthalingam P , Arfeen M
Ref : Pharmaceuticals (Basel) , 15 : , 2022
Abstract : Mani_2022_Pharmaceuticals.(Basel)_15_
ESTHER : Mani_2022_Pharmaceuticals.(Basel)_15_
PubMedSearch : Mani_2022_Pharmaceuticals.(Basel)_15_
PubMedID: 36559014

Title : Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study - Mani_2022_Molecules_27_
Author(s) : Mani V , Arfeen M , Rabbani SI , Shariq A , Amirthalingam P
Ref : Molecules , 27 : , 2022
Abstract : Mani_2022_Molecules_27_
ESTHER : Mani_2022_Molecules_27_
PubMedSearch : Mani_2022_Molecules_27_
PubMedID: 36364190